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a b s t r a c t
Liposarcomas are malignant tumors of the soft tissue. Myxoid liposarcoma is the second
most common subtype of these tumors in adults. It accounts for approximately 20% of all
malignant soft tissue tumors [1,2]. Peak of its incidence occurs between 40 to 60 years of age
with relatively indolent clinical course Matsumoto et al. (2007) [3], Cho et al. (2010) [4],
Faiman et al. (2005) [5]. Typical localizations of myxoid liposarcoma comprise limbs,
particularly thighs with a tendency to metastasize into extrapulmonary sites such as
retroperitoneum, mediastinum, bones. Cardiac metastases are extremely rare.
We present a case of a 36-year-old man with a history of recurrent myxoid liposarcoma.
Primary location was in the left popliteal area. After extirpation of the tumor, metastatic
tumor was subsequently revealed in the right axilla. Each surgical extirpation was followed
by radiation therapy and brachytherapy. Cardiac metastasis was accidentally diagnosed
with PET/CT during the staging process. The patient was asymptomatic andwas admitted to
our institution for further diagnostics and treatment. After conﬁrmation of its location, the
tumor was excised. Histological examination revealed myxoid liposarcoma.
# The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o.
All rights reserved.
.2014IntroductionLiposarcoma is the second most common type of soft tissue
sarcomas in adults after ﬁbrous histiocytoma [3,5]. It
accounts for approximately 20% of all malignant soft* Corresponding author. Tel.: +420 261365108; fax: +420 26136 2989.
E-mail address: wirtx@seznam.cz (R. Virtová).
http://dx.doi.org/10.1016/j.crvasa.2013.07.004
0010-8650/# The Czech Society of Cardiology. Published by Else2014tissue tumors [3]. We recognize ﬁve histologic types: well
differentiated, dedifferentiated, myxoid, round cell, and
pleomophic. Myxoid variant is the second most common
type, which is seen most often in fourth and ﬁfth decade
of life. Myxoid liposarcoma is characterized by long
disease duration and multiple recurrences [4]. We presentvier Urban & Partner Sp.z o.o. All rights reserved..
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coma.
Case presentation36-year-old man without history of cardiac disease was
treated for the ﬁrst time for myxoid liposarcoma in the left
popliteal area in 2007. After surgical resection and radiation
therapy, the tumor recurred in the right axilla in 2009. After
extirpation of the tumor without adjuvant therapy, another
local recurrence was found in 2011. The axillary exenteration
was performed repeatedly in April 2011 and March 2012.
Positron emission tomography–computed tomography (PET/
CT) was carried out as a part of staging process during
oncologic follow-up. The scan revealed a hypodense round
lesion in the interventricular septum of the heart without
abnormal 18F-ﬂuorodeoxyglucose (FDG) accumulation, which
meant that glucose consumption was not increased in the
lesion. Nonspeciﬁcally increased accumulation of the agent
was found in the margins of the lesion, which probably
represented physiological variant of imaging of increased[(Fig._1)TD$FIG]
Fig. 1 – PET/CT scan (performed at Na Homolce Hospital). CT com
PET/CT fused images (middle panel); top panels shows horizont
show short axis slices (viewed from apex). A round hypodense n
septum on the CT scan. The nodule does not demonstrate incre
are usual in low grade liposarcoma. Slightly increased FDG accu
inhomogeneous distribution of glycolysis in myocardium.glycolytic activity in surrounding myocardium (Fig. 1). The
patient was referred to our institution (IKEM) for further
diagnostic work-up and treatment. He had no symptoms at
presentation, and physical examination did not reveal any
signs of the disease. ECG was normal. Transthoracic echocar-
diogram conﬁrmed a nodule 3125 mm2 in size in the middle
segment of the interventricular septum involving also the
basal segment close to the mitral annulus. The tumor
protruded into left ventricular cavity andmoved with septum.
The tumor neither caused hemodynamic compromise nor
compressed adjacent structures. Ejection fractions of both
ventricles were normal, as well as all valves (Fig. 2A, B).
Magnetic resonance imaging conﬁrmed presence of the round
lesion 22 mm in diameter with well-deﬁned borders and
morphology reminding myxoid tissue (Fig. 3). Subsequently,
the patient underwent operation, and the tumor of the septum
was resected (Fig. 4A, B, C). The operation and early postopera-
tive course was uncomplicated without arrhythmias during
monitoring.Histological examinationconﬁrmedametastasisof
myxoid liposarcoma (Fig. 5). The patient has been followed up
for 10 months and has had no signs of disease recurrence
according to MRI and PET/CT scan (Figs. 6A, B, and 7).ponent (left panel), PET component (right panel), and FDG-
al long axis slices (viewed from below), and bottom panels
odule of 22 mm in diameter is visible in the interventricular
ased glycolytic activity on the FDG-PET scan. Such findings
mulation in surrounding tissues represents physiological
[(Fig._2)TD$FIG]
Fig. 2 – Echocardiography – (A) apical four chamber view and
(B) short axis view.
[(Fig._3)TD$FIG]
Fig. 3 –Magnetic resonance imaging: a hyperintense nodule
in the interventricular septum (native 2D T2-weighted TSE
imaging).
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 2 7 4 – e 2 7 8e276DiscussionMalignant heart tumors are very rare. The most common
primary tumors occurring in heart are sarcomas. Secondary
heart tumors, i.e., metastases of other malignancies as
melanoma, lung carcinoma, lymphoma, or breast cancer,
are 20–40 times more often than primary lesions [5].
Liposarcoma is rarely occurring mesenchymal tumor belong-
ing to soft tissue sarcomas. It is the second most common
malignity of this type in adults after ﬁbrous histiocytoma [3,5],
which accounts for about 20% of all malignant soft tissue
tumors [1]. The incidence of liposarcoma peaks between 40
and 60 years of age and it usually has relatively long clinically
[(Fig._4)TD$FIG]Fig. 4 – View of (A) the interventricular septum with the tumor a
interventricular septum after ventriculotomy closure with a prossilent course [4,7]. Myxoid liposarcoma is typically found in the
extremities, particularly legs; it also occurs quite often in the
buttock, retroperitoneum, abdominal cavity, or chestwall [4,5].
Primary tumor in our casewas localized in the popliteal area of
the left lower extremity. Although it is typical for liposarcomas
that they usually metastasize to the lungs, myxoid liposar-
coma tends to spread also to extrapulmonary sites as soft
tissues,mediastinum, bones, and heart [4,8]. Metastases to the
spine are extremely rare [4]. In our case, the ﬁrst metastasis of
the tumor was found in the right axilla.
Heart metastases are also very rare, and their clinical
presentation is heterogeneous. Many patients have no symp-
toms, and the diagnosis is not usually made until post mortem
[9]. In our patient, the diagnosis was established during staging
for primary tumor. The most common sign in symptomatic
patients is pericardial involvement with pericardial effusion.
Other usual signs are heart failure, conduction abnormalities,
tachyarrhythmia, mechanical obstruction, valve disease, or
myocardial rupture [3,7,10]. Symptoms are dependent upon the
site and size of the tumor. Tumors in the right side of the heart
cause symptoms such as dyspnea and hemoptysis. The ones infter ventriculotomy, (B) the excised tumor, and (C) the
thetic patch.
[(Fig._5)TD$FIG]
Fig. 5 – Microscopic findings (Institute of Pathology,
Teaching Hospital in Motol), hematoxylin and eosin stain,
magnification 100T. The tumor contains relatively small
amount of cells that are oval, slightly elongated, or star
shaped embedded in an abundant matrix with network of
thin capillaries. Cells containing vacuoles and resembling
lipoblasts are present.
[(Fig._6)TD$FIG]
Fig. 6 – Echocardiography after tumor excision – (A) apical
for chamber view and (B) short axis view.
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due to left ventricular outﬂow obstruction. Also neurological
symptoms such as movement disorders, vision disorders, and
sensory symptoms can be seen [5,6,7].
In our patient, histological examination demonstrated a
tumor surrounded with myocardium and partially with a thin
ﬁbrous capsule. The tumor contained relatively small amount
of cells that were oval to slightly elongated or star shaped
embedded in an abundant myxoid matrix (Fig. 5). No mitotic
activitywas found. Proliferation rate assessed by expression of
the antigenKi-67was about 2%. Themicroscopicﬁndingswere
similar as in the previous histological examinations of speci-
mens from the left popliteal area and right axilla. It is of note
that bothmyxoid and round cell liposarcoma are characterized
by chromosomal translocations – fusion of the gene CHOP on
the chromosome 12p 13 and the gene FUS on the chromosome
16q 11. These translocationswere also detected in our case. The
same chromosomal translocations were also retrospectively
found in the previous specimen from the right axilla. Those
ﬁndingsconﬁrmedunequivocally that thenodule in the septum
in our patient was a metastasis of myxoid liposarcoma.
Diagnosticworkup is based onmedical history andphysical
examination complemented with noninvasive imaging tech-
niques. The most important imaging methods are CT
angiography andmagnetic resonance imaging, which are able
to characterize in detail pathological tissue. Both methods
bring important information on tumor homogeneity, presence
of adipose cells and calciﬁcation, percentage of necrotic or
cystic components, tumor vascularization, size, location and
relation to surrounding structures [3,9]. In our case, magnetic
resonance imaging described size and location of the tumor
and also its characteristics reminding myxoma (Fig. 3).
FDG-PETor PET/CT is increasingly used in clinical staging of
most tumors. This method enables detection of metabolic
activity of viable neoplastic tissue based on increasedglycolysis in tumor cells. It signiﬁcantly helps to assess
clinical stage of the disease, extent of the metabolically active
tumor compartment in large tumors, and prognosis. In case of
sarcomas, including myxoid sarcoma, this method is more
suitable for grading. In our patient, the CT component of the
CT/PET scan revealed accidentally a nodule in the interve-
tricular septum, and the negative PET component indicated
rather low grade tumor (Fig. 1). Postoperative examination still
has not shown any signs of tumor recurrence [11]. The
prognosis of the disease is dependent on several factors such
as the size of the primary tumor, its location, histology, and the
presence of metastases [12]. The primary treatment of
liposarcoma is radical resection with adequate margin of
normal tissue [5,13]. Adjuvant chemotherapy is not recom-
mended as standard treatment, but it can be considered in
individual cases when the tumor is very large or not removed
completely, or risk factors are present. Systemic chemothera-
py is indicated in generalized disease. The ﬁrst choice
treatment is doxorubicin with ifosfamide; the second choice
is trabectedin, ifosfamide, or tyrosine kinase inhibitor pazo-
panib. Dacarbazine represents further treatment option in
selected pretreated patients. When anthracyclines are admin-
istered, initial ejection fraction of the left ventricle needs to be
established, and the cumulative dose, which represents the
limiting factor of doxorubicin therapy continuation, has to be
monitored [6]. The goal of radiation therapy is reduction of local
recurrence in patients with large tumors and non-cardiac
[(Fig._7)TD$FIG]
Fig. 7 – Magnetic resonance imaging: after excision of the
tumor in the interventricular septum (native 2D T2-
weighted TSE imaging).
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 2 7 4 – e 2 7 8e278surgical excisions [2]. Contrary to other more often seen
sarcomas of soft tissues, myxoid and round cell form of
liposarcoma are highly radiosensitive [4,5,13]. However, consid-
ering the fact that theheart shouldnotbe treatedwith radiation,
and the discussed tumor has low chemosensitivity, surgery is
theonly option in such cases. Ourpatientwasalso treated solely
surgically. No radiation therapy or chemotherapy has been
indicated in this case since the tumor had very low proliferation
activity, and no signs of recurrence have been identiﬁed so far.
ConclusionMyxoid liposarcoma is the second most common type of soft
tissue sarcoma. Its main features are long disease course and
multiple recurrences. Diagnostic workup is based on nonin-
vasive imaging techniques, particularly magnetic resonance
imaging. Surgical resection is the treatment of choice, and is
sometimes accompanied by radiotherapy. The prognosis of
the disease is uncertain.
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